MultIceNtre non-intERVentional study for efficacy,safety evaluation of BREZTRI in pts with COPD in RussiA

Trial Identifier: D5980R00097
Sponsor: AstraZeneca
Start Date: December 2023
Primary Completion Date: December 2024
Study Completion Date: December 2024
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Russia Blagoveshchensk, Russia
Russia Kazan, Russia
Russia Krasnodar, Russia
Russia Krasnoyarsk, Russia
Russia Moscow, Russia
Russia Nizhniy Novgorod, Russia
Russia Novosibirsk, Russia
Russia Omsk, Russia
Russia Rostov-on-Don, Russia
Russia Ryazan, Russia
Russia Saint-Petersburg, Russia
Russia Ufa, Russia
Russia Volgograd, Russia
Russia Yekaterinburg, Russia